S&P Keeps Hold Opinion on Merck

Analyst Herman Saftlas believes the drug maker can manage Vioxx liabilities. Plus: opinions on Northwest Airlines, Eyetech, and more

Merck (MRK ): Reiterates 3 STARS (hold)

To continue reading this article you must be a Bloomberg Professional Service Subscriber.